What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
PMID 23870976
IGF-1 can act over its putative receptor (IGF-1R) or it can also bind to the insulin receptor (IR), albeit with less affinity [9]
Like any medication, they carry some risks, which is why proper medical supervision and screening matter
Pharmaceutical companies have created amazing drugs and solutions that have helped and even saved millions of lives
Our bodies emit heat, including heat in the infrared spectrum